Understanding Retina and Vitreous Care for Your Vision
Understanding the Retina and Vitreous
The retina is a thin layer of light-sensitive nerve tissue that lines the back of the eye. When light enters your eye, it passes through the lens and focuses on the retina. The retina then converts those images into electrical signals. These signals travel through the optic nerve to the brain, which interprets them as the images you see.
At the center of the retina is a small area called the macula. The macula is responsible for sharp, detailed central vision. It is the part of the retina you use for reading, driving, and recognizing faces.
The vitreous is a clear, gel-like substance that fills the space between the lens and the retina. It helps the eye maintain its round shape and allows light to pass through to the retina. As you age, the vitreous can change in consistency, shrink, or pull away from the retina. These changes can sometimes lead to vision problems.
The retina and vitreous function as a connected system. The vitreous is attached to the surface of the retina, especially around the edges and near the optic nerve. When the vitreous changes with age or disease, it can tug on the retina. This pulling can cause tears, detachments, or swelling. Conditions that affect either the vitreous or the retina are collectively called vitreoretinal diseases.
Who Is Affected and Risk Factors
Aging is the most common risk factor for vitreoretinal disease. Most people experience posterior vitreous detachment (a condition where the vitreous gel separates from the retina) after age 60. This occurs once in each eye and is usually not sight-threatening. However, it can occasionally lead to retinal detachment or epiretinal membrane (a thin layer of scar tissue on the retina surface).
Vitreoretinal disease may develop secondary to diabetes or other systemic health conditions. Diabetic retinopathy, one of the most common retinal diseases, occurs when high blood sugar damages the tiny blood vessels in the retina. Other health conditions that increase the risk of retinal problems include high blood pressure, autoimmune disorders, and blood clotting disorders.
Retinal diseases affect millions of people. Consider these figures:
- An estimated 19.8 million Americans aged 40 and older were living with age-related macular degeneration in 2019. Of these, about 1.49 million had vision-threatening forms (CDC, 2019).
- Rhegmatogenous retinal detachment (a type caused by a tear in the retina) occurs in an estimated 10 to 18 per 100,000 people per year in the United States (PMC, 2022).
- Retinal breaks are found in 8 to 16 percent of patients with acute symptomatic posterior vitreous detachment. If untreated, these breaks may progress to retinal detachment in 30 to 50 percent of cases (PMC, 2022).
Several additional factors can increase the risk of vitreoretinal disease. These include severe nearsightedness, prior eye surgery, eye trauma, and a family history of retinal detachment. Research also shows that longer duration and larger extent of detachment are associated with more severe complications (PMC, 2022).
Signs and Symptoms to Watch For
Certain symptoms involving the retina and vitreous are medical emergencies. If you experience any of the following, see a retina specialist or go to the emergency room immediately:
- A sudden increase in floaters (mobile blurry shadows that drift across your vision)
- Flashes of light, especially streaks of light at the side of your vision
- A curtain or shadow spreading over part of your visual field
- Sudden vision loss in one eye
- Severe eye pain
Not all retinal conditions present with sudden symptoms. Some develop slowly over time. Gradual symptoms may include dimming of central or peripheral vision, night blindness, and distortion of printed words when reading. Wavy or bent lines in your central vision and extreme light sensitivity can also signal a retinal issue. These symptoms should be evaluated by a retina specialist promptly, even if they seem mild.
Mild floaters in your vision are normal and common. However, a sudden increase in floaters is often the first symptom of posterior vitreous detachment. During this process, floaters are frequently accompanied by flashes of light. These flashes tend to be most noticeable in dark surroundings. In many cases, these symptoms become less intense over several weeks. Still, any sudden onset of floaters or flashes warrants a prompt eye examination to rule out a retinal tear or detachment.
Diagnosis and Testing
A retina specialist will typically begin with a comprehensive dilated eye examination. During this exam, special drops widen your pupils. The specialist can then look at the retina and vitreous with high-powered lenses. This allows a detailed view of the back of the eye, revealing tears, detachments, swelling, bleeding, or other abnormalities.
Modern retina care relies on several imaging technologies to detect disease at very early stages. Optical coherence tomography, often called OCT, uses light waves to create detailed cross-section images of the retina. This test can reveal fluid, swelling, or thinning in the retinal layers. Fluorescein angiography involves injecting a dye into the bloodstream. The retinal blood vessels are then photographed as the dye passes through them. This helps identify leaking vessels and areas of poor blood flow.
When the view of the retina is blocked by bleeding or cloudy vitreous, an ultrasound of the eye may be used. This test uses sound waves to create an image of the structures inside the eye. Additional tests may include electroretinography, which measures the electrical responses of retinal cells. Visual field testing, which maps your peripheral vision, may also be performed.
Treatment Options
Intravitreal injections (injections of medication directly into the eye) are a standard treatment for several retinal diseases. Anti-VEGF agents block vascular endothelial growth factor, a protein that drives abnormal blood vessel growth and leakage. These injections are used to treat wet age-related macular degeneration, diabetic macular edema (swelling in the macula caused by diabetes), and retinal vein occlusion. Anti-VEGF therapy is specifically for conditions involving abnormal vessel growth or leakage.
Several anti-VEGF medications are available:
- Eylea (aflibercept): typically given every 4 to 8 weeks after an initial loading phase
- Eylea HD (high-dose aflibercept): may extend dosing intervals to every 8 to 16 weeks after loading
- Lucentis (ranibizumab): typically given every 4 weeks
- Vabysmo (faricimab): a bispecific antibody that may allow dosing intervals of every 4 to 16 weeks
- Avastin (bevacizumab): FDA-approved for cancer and used off-label for eye conditions, typically given every 4 to 6 weeks
- Biosimilar options such as Cimerli (ranibizumab-eqrn) and Byooviz (ranibizumab-nuna) are also available
Geographic atrophy is an advanced form of dry age-related macular degeneration. It is a different condition from wet AMD and requires different treatments. Two complement inhibitors are now available to slow its progression. Syfovre (pegcetacoplan), a complement inhibitor that targets C3, was the first intravitreal therapy approved by the FDA for geographic atrophy. Izervay (avacincaptad pegol), a complement inhibitor that targets C5, offers another option. These treatments slow further vision loss but do not reverse damage already done.
For certain conditions involving retinal inflammation or swelling, steroid implants can be placed inside the eye. Ozurdex (dexamethasone implant) is a biodegradable implant that slowly releases medication over weeks to months. Iluvien (fluocinolone acetonide implant) provides sustained steroid delivery for up to three years. These are used in cases of diabetic macular edema, retinal vein occlusion, and certain types of uveitis (inflammation inside the eye).
Laser photocoagulation (thermal laser applied to the retina) remains an important tool in retina care. It can be used to seal retinal tears and reduce abnormal blood vessel growth in diabetic retinopathy. Photodynamic therapy is another laser-based approach. It uses a light-activated drug to treat certain types of abnormal blood vessels under the retina.
When retinal conditions are more severe, surgery may be needed. Pars plana vitrectomy (a surgery in which the vitreous gel is removed from the eye) is one of the most common retinal surgeries. It allows the surgeon to access the retina directly to repair detachments, remove scar tissue, or clear blood from the vitreous cavity.
Other surgical options include:
- Scleral buckle: a silicone band placed around the eye to support the retina
- Pneumatic retinopexy: injection of a gas bubble to push the retina back into place
- Cryopexy: freezing treatment to seal retinal tears
What to Expect
Intravitreal injections are performed in an office setting and take only a few minutes. The eye is numbed with anesthetic drops, and the surface is cleaned with an antiseptic solution. A very small needle is used to inject medication into the vitreous cavity. Most patients feel pressure rather than sharp pain. Some mild discomfort, redness, or floaters may occur afterward and typically resolve within a day or two.
Retinal surgeries such as vitrectomy are usually performed under local anesthesia. This means you are awake but your eye is numb. The surgery may take one to several hours depending on the complexity. Recovery times vary. Some patients need to maintain a specific head position for days to weeks if a gas bubble was placed inside the eye. Follow-up visits are important to monitor healing and check for complications.
Most retinal conditions are chronic and require ongoing monitoring. Your retina specialist will create a treatment plan that may include regular imaging, repeated injections, or periodic examinations. Treatment frequency often depends on how your eye responds. Newer medications and delivery systems aim to reduce the number of visits needed while maintaining results.
Living with a Retinal Condition
Many retinal diseases require repeated treatments over months or years. Establishing a consistent routine with regular appointments helps maintain the best possible vision. Missing or delaying treatments can allow disease progression. If the treatment schedule feels overwhelming, discuss your concerns with your retina specialist. Newer options may offer longer intervals between visits.
In addition to medical treatment, you can take steps to support your eye health. Managing underlying conditions like diabetes and high blood pressure is critical. Eating a diet rich in leafy green vegetables, wearing UV-protective sunglasses, and avoiding smoking can also support retinal health. For those with age-related macular degeneration, your retina specialist may recommend specific nutritional supplements based on the AREDS2 formula.
If a retinal condition has reduced your vision significantly, low vision rehabilitation can help. Low vision specialists can recommend magnifying devices, special lighting, and adaptive technologies that make daily tasks easier. Many people with retinal conditions continue to live independently with the right support and tools.
When to See a Retina Specialist
A retina specialist is a medical doctor who completed medical school, residency training in ophthalmology, and additional fellowship training in diseases and surgery of the retina and vitreous. Retina specialists are board-certified ophthalmologists with the highest level of expertise in this area (ASRS). The ASRS includes more than 3,000 members across the United States and 63 countries (ASRS).
Optometrists and primary care doctors can screen for retinal problems during routine eye exams. If they detect signs of retinal disease, they will refer you to a retina specialist for further evaluation and treatment. People with diabetes should have annual dilated eye exams to screen for diabetic retinopathy. Those with a family history of macular degeneration or retinal detachment should also discuss screening schedules with their eye care provider.
Some retinal emergencies, such as retinal detachment, can lead to severe and irreversible vision loss if not treated quickly. If you experience sudden floaters, flashes of light, a shadow over your vision, or sudden vision loss, see a retina specialist or go to the emergency room immediately. Early treatment significantly improves outcomes for many retinal emergencies.
Questions and Answers
A general ophthalmologist is trained to diagnose and treat a wide range of eye conditions, including performing cataract surgery and prescribing glasses. A retina specialist has completed all of that training plus one to two additional years of fellowship focused on the retina and vitreous. This additional training covers advanced medical treatments like intravitreal injections and complex surgeries like vitrectomy. For conditions affecting the back of the eye, a retina specialist has the most specialized expertise.
Intravitreal injections have been used for many years and have a strong safety record. As with any medical procedure, there are risks, including infection, bleeding, and increased eye pressure. Serious complications are uncommon. The eye is numbed before the injection, though some discomfort during and after the procedure is normal. Your retina specialist will explain the specific risks and benefits based on your condition.
The outcome depends on the specific condition and how quickly treatment begins. Some retinal diseases can be managed effectively to preserve existing vision and slow further loss. In certain cases, treatment may improve vision. However, damage to the retinal nerve cells is often difficult to fully reverse. This is why early detection and timely treatment are so important for protecting long-term vision.
Treatment frequency varies depending on the diagnosis and how your eye responds. Some patients with wet age-related macular degeneration or diabetic macular edema may need injections every month at first. The frequency often decreases as the condition stabilizes. Newer medications like Eylea HD and Vabysmo may allow longer intervals between treatments. Your retina specialist will adjust the schedule based on imaging results and your visual response at each visit. It is important to note that anti-VEGF injections are used specifically for wet AMD and are not a treatment for dry AMD.
Untreated retinal conditions can lead to progressive and sometimes irreversible vision loss. For example, an untreated retinal tear can progress to a full retinal detachment, which is a surgical emergency. Untreated diabetic retinopathy can cause severe bleeding inside the eye and scarring on the retina. Dry age-related macular degeneration can advance to geographic atrophy, which causes expanding areas of vision loss. Regular monitoring and prompt treatment give you the best chance of preserving your sight.